Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bonella

Showing results (101-110 of 193) with videos related to

Pageof 20
Sort By:
Respiration; International Review of Thoracic Diseases|October 10, 2009
Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung diseaseAi Cui, Olaf Anhenn, Dirk Theegarten, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|January 16, 2015
A pilot study: a combined therapy using polymyxin-B hemoperfusion and extracorporeal membrane oxygenation for acute exacerbation of interstitial pneumoniaJunji Itai, Shinichiro Ohshimo, Yoshiko Kida, et al.
Scandinavian Journal of Gastroenterology|March 14, 2007
Omeprazole reduces the response to capsaicin but not to methacholine in asthmatic patients with proximal refluxMarcello Ferrari, Luigi Benini, Emanuele Brotto, et al.
Pneumologie (Stuttgart, Germany)|May 31, 2017
[German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017]Jürgen Behr, Andreas Günther, Francesco Bonella, et al.
Pneumologie (Stuttgart, Germany)|July 6, 2017
[German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017]Jürgen Behr, Andreas Günther, Francesco Bonella, et al.
Lung|January 9, 2025
Continued Treatment with Nintedanib in Patients with Progressive Pulmonary Fibrosis: Data from INBUILD-ONWim A Wuyts, Francesco Bonella, Nazia Chaudhuri, et al.
Pneumologie (Stuttgart, Germany)|September 14, 2021
A New Tool to Assess Quality of Life in Patients with Idiopathic Pulmonary Fibrosis or Non-specific Interstitial PneumoniaDetlef Kirsten, Ulrike de Vries, Ulrich Costabel, et al.
Immunobiology|September 23, 2020
Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessmentMiriana d'Alessandro, Laura Bergantini, Rosa Metella Refini, et al.
Pneumologie (Stuttgart, Germany)|January 18, 2018
German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017Jürgen Behr, Andreas Günther, Francesco Bonella, et al.
Respiration; International Review of Thoracic Diseases|February 8, 2018
Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary FibrosisMichael Kreuter, Ulrich Costabel, Luca Richeldi, et al.
Pageof 20

Showing results (101-110 of 193) with videos related to

Sort By:
Pageof 20
Respiration; International Review of Thoracic Diseases|October 10, 2009
Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung diseaseAi Cui, Olaf Anhenn, Dirk Theegarten, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|January 16, 2015
A pilot study: a combined therapy using polymyxin-B hemoperfusion and extracorporeal membrane oxygenation for acute exacerbation of interstitial pneumoniaJunji Itai, Shinichiro Ohshimo, Yoshiko Kida, et al.
Scandinavian Journal of Gastroenterology|March 14, 2007
Omeprazole reduces the response to capsaicin but not to methacholine in asthmatic patients with proximal refluxMarcello Ferrari, Luigi Benini, Emanuele Brotto, et al.
Pneumologie (Stuttgart, Germany)|May 31, 2017
[German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017]Jürgen Behr, Andreas Günther, Francesco Bonella, et al.
Pneumologie (Stuttgart, Germany)|July 6, 2017
[German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017]Jürgen Behr, Andreas Günther, Francesco Bonella, et al.
Lung|January 9, 2025
Continued Treatment with Nintedanib in Patients with Progressive Pulmonary Fibrosis: Data from INBUILD-ONWim A Wuyts, Francesco Bonella, Nazia Chaudhuri, et al.
Pneumologie (Stuttgart, Germany)|September 14, 2021
A New Tool to Assess Quality of Life in Patients with Idiopathic Pulmonary Fibrosis or Non-specific Interstitial PneumoniaDetlef Kirsten, Ulrike de Vries, Ulrich Costabel, et al.
Immunobiology|September 23, 2020
Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessmentMiriana d'Alessandro, Laura Bergantini, Rosa Metella Refini, et al.
Pneumologie (Stuttgart, Germany)|January 18, 2018
German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017Jürgen Behr, Andreas Günther, Francesco Bonella, et al.
Respiration; International Review of Thoracic Diseases|February 8, 2018
Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary FibrosisMichael Kreuter, Ulrich Costabel, Luca Richeldi, et al.
Pageof 20